NAVIGATING THE NEW HEALTH
DEAD

Serial Number

77798327

Owner

QUINTILES TRANSNATIONAL CORP.

Attorney

Arlene D. Hanks

First Use Date

Jan 20, 2010

Filing Date

Aug 6, 2009

Add to watchlist:

No watchlists yet
View on USPTO

NAVIGATING THE NEW HEALTH Trademark

Serial Number: 77798327 • Registration: 4042560

NAVIGATING THE NEW HEALTH is a trademark filed by QUINTILES TRANSNATIONAL CORP. on August 6, 2009. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

QUINTILES TRANSNATIONAL CORP. (78 trademarks)

Suite 200
Durham, NC 27703

Entity Type: 03

Trademark Details

Filing Date

August 6, 2009

Registration Date

October 18, 2011

First Use Anywhere

January 20, 2010

First Use in Commerce

January 20, 2010

Published for Opposition

December 14, 2010

Cancellation Date

May 25, 2018

Goods & Services

Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, and pharmaceutical and health products, and distributing course materials in connection therewith

Providing financial services in the pharmaceutical, biotechnology and life sciences fields, namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies; capital funding services to pharmaceutical, biotechnology and life sciences companies for the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives; and providing financial consultation in connection with all of the above

Regulatory compliance research in the development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; regulatory compliance consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory compliance audits for others to ensure the accuracy and validity of information developed in the research and testing of drugs, devices and biologics in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations; providing regulatory information, namely, providing information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory implementation services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirements

Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medicine and pharmaceuticals

Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; research and development services with respect to the scientific aspects of healthcare policy; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others

Filing History

CANCELLED SEC. 8 (6-YR)
May 25, 2018 C8..
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 19, 2016 ASCK
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 18, 2016 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 12, 2016 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 27, 2015 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2015 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2014 TCCA
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 16, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 15, 2011 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 14, 2011 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 9, 2011 SUPC
USE AMENDMENT FILED
Aug 5, 2011 IUAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2011 TCCA
TEAS STATEMENT OF USE RECEIVED
Aug 5, 2011 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 8, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 14, 2010 NPUB
PUBLISHED FOR OPPOSITION
Dec 14, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 9, 2010 PREV
ASSIGNED TO LIE
Nov 9, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2010 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 28, 2010 ERFR
ATTORNEY REVIEW COMPLETED
Oct 26, 2010 ATRV
DIVISIONAL PROCESSING COMPLETE
Oct 22, 2010 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 21, 2010 AITU
DIVISIONAL REQUEST RECEIVED
Sep 23, 2010 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 23, 2010 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
May 5, 2010 GNFN
FINAL REFUSAL E-MAILED
May 5, 2010 GNFR
FINAL REFUSAL WRITTEN
May 5, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2010 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 31, 2010 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2009 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2009 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2009 CNRT
ASSIGNED TO EXAMINER
Nov 11, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2009 NWOS
NEW APPLICATION ENTERED
Aug 10, 2009 NWAP